VUGENE is an AI-integrated multi-omic data interpretation platform for therapeutic R&D. We turn complex biological datasets into clear mechanism-of-action (MoA) insights in days instead of months. The platform integrates transcriptomics, proteomics, epigenomics, metabolomics, pre-clinical and clinical data across studies and biological models, combining advanced AI/ML with deep human scientific expertise delivering decision-ready biological interpretation.

VUGENE has been cash-flow positive since inception, driven by early client demand and disciplined capital deployment. We have completed 6,000+ projects across discovery and translational research and served 30+ organizations, including Tier-1 life sciences customers. 85% of revenue comes from the U.S., with ~80% recurring revenue as VUGENE speeds up Executive decisions.

Our platform is built for scale. It is subscription and customization ready. Our ideal customer profiles (ICP) are well funded biotech, Pharma, CROs.